MANTI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 1.974
AS - Asia 1.640
EU - Europa 1.404
SA - Sud America 236
AF - Africa 205
OC - Oceania 3
Totale 5.462
Nazione #
US - Stati Uniti d'America 1.904
RU - Federazione Russa 693
SG - Singapore 656
CN - Cina 432
IT - Italia 335
BR - Brasile 192
VN - Vietnam 154
KR - Corea 145
CI - Costa d'Avorio 93
FR - Francia 72
BD - Bangladesh 67
IE - Irlanda 67
GB - Regno Unito 49
NG - Nigeria 48
HK - Hong Kong 43
IN - India 40
NL - Olanda 40
DE - Germania 37
CA - Canada 35
FI - Finlandia 31
MX - Messico 21
AR - Argentina 20
IQ - Iraq 19
PL - Polonia 19
ES - Italia 18
ZA - Sudafrica 17
BJ - Benin 15
JP - Giappone 13
ID - Indonesia 12
SE - Svezia 11
EC - Ecuador 10
PK - Pakistan 9
SN - Senegal 8
TR - Turchia 8
UA - Ucraina 6
AZ - Azerbaigian 5
CO - Colombia 5
CZ - Repubblica Ceca 5
EG - Egitto 5
MA - Marocco 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
HN - Honduras 4
JM - Giamaica 4
PH - Filippine 4
AU - Australia 3
CL - Cile 3
KE - Kenya 3
LB - Libano 3
OM - Oman 3
PY - Paraguay 3
RS - Serbia 3
AL - Albania 2
BE - Belgio 2
CH - Svizzera 2
CR - Costa Rica 2
DZ - Algeria 2
ET - Etiopia 2
IR - Iran 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LT - Lituania 2
MD - Moldavia 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
RE - Reunion 2
TH - Thailandia 2
TN - Tunisia 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
DK - Danimarca 1
GA - Gabon 1
GT - Guatemala 1
IL - Israele 1
JO - Giordania 1
KH - Cambogia 1
LU - Lussemburgo 1
MK - Macedonia 1
MW - Malawi 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
VA - Santa Sede (Città del Vaticano) 1
VE - Venezuela 1
Totale 5.462
Città #
Dallas 426
Singapore 397
Moscow 357
Santa Clara 231
Hefei 206
San Jose 199
Ashburn 151
Seoul 144
Los Angeles 139
Abidjan 93
Dublin 68
Beijing 61
Ho Chi Minh City 59
Chandler 58
New York 58
Lauterbourg 52
Chicago 47
Council Bluffs 42
Buffalo 40
Hong Kong 39
Catania 32
Hanoi 31
Abuja 30
São Paulo 30
Boardman 28
Orem 23
Lappeenranta 22
Denver 21
Civitanova Marche 20
Milan 20
Rome 20
Amsterdam 18
Lagos 18
London 17
Warsaw 17
Brooklyn 16
Atlanta 15
Cotonou 15
Cambridge 14
Chennai 14
Lawrence 14
Bremen 13
Poplar 13
Tokyo 13
Houston 12
Montreal 11
Rio de Janeiro 10
Stockholm 10
Johannesburg 9
Mexico City 9
Naples 9
Paris 9
Bắc Ninh 8
Dakar 8
Frankfurt am Main 8
Haiphong 8
Phoenix 8
Bologna 7
Palermo 7
Baghdad 6
Bernareggio 6
Biancavilla 6
Da Nang 6
Dhaka 6
Genoa 6
Manchester 6
Querétaro 6
San Francisco 6
Ankara 5
Boston 5
Charlotte 5
Redondo Beach 5
Seattle 5
Tashkent 5
Turku 5
Cesa 4
Dong Ket 4
Helsinki 4
Kingston 4
Manaus 4
Mumbai 4
Munich 4
New Delhi 4
Reggio Emilia 4
Toronto 4
Turin 4
Verona 4
Baku 3
Bari 3
Belo Horizonte 3
Brasília 3
Brescia 3
Buenos Aires 3
Cagliari 3
Cairo 3
Calgary 3
Casablanca 3
Curitiba 3
Des Moines 3
Erbil 3
Totale 3.650
Nome #
High-Flow Nasal Cannula Oxygen Therapy: Physiological Mechanisms and Clinical Applications in Children 174
Headache and Diplopia after Rapid Maxillary Expansion: A Clue to Underdiagnosed Pseudotumor Cerebri Syndrome? 152
Protracted bacterial bronchitis: more to know 148
Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis 139
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years 138
Lactoferrin: Cytokine modulation and application in clinical practice 133
Impact of COVID-19 Pandemic and Lockdown on the Epidemiology of RSV-Mediated Bronchiolitis: Experience from Our Centre 129
Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: Our experience and literature review 129
Comparative Analysis of Pediatric Hospitalizations during Two Consecutive Influenza and Respiratory Virus Seasons Post-Pandemic 125
Cystic Fibrosis and Cancer: Unraveling the Complex Role of CFTR Gene in Cancer Susceptibility 119
Minor pulmonary malformations in a child 117
Monoclonal antibodies in treating food allergy: A new therapeutic horizon 114
Positive impact of insulin treatment on clinical trend in cystic fibrosis patients: a retrospective study 113
Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review 113
Nutraceuticals in the prevention of viral infections, including covid-19, among the pediatric population: A review of the literature 112
Addition of a nutraceutical to montelukast or inhaled steroid in the treatment of wheezing during COVID-19 pandemic: a multicenter, open-label, randomized controlled trial 111
Epidemiological shifts in bronchiolitis patterns and impact of the COVID-19: A two-season comparative study 105
Nasal Nitric Oxide and Nasal Cytology as Predictive Markers of Short-Term Sublingual Allergen-Specific Immunotherapy Efficacy in Children with Allergic Rhinitis 103
Nocturnal non invasive ventilation in normocapnic cystic fibrosis patients: A pilot study 102
Cystic Fibrosis and Oxidative Stress: The Role of CFTR 101
Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cardiorespiratory Polygraphy Parameters and Respiratory Muscle Strength in Cystic Fibrosis Patients with Severe Lung Disease 100
Dupilumab Treatment in Children Aged 6–11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study 98
Combining biologics and CFTR modulators is safe: A pilot, observational, monocenter study 98
Fungi and non-tuberculous mycobacteria: emerging pathogens in cystic fibrosis 97
Safety of biologics in severe asthmatic patients with SARS‐CoV‐2 infection: A prospective study 94
Omalizumab treatment in a 12 year-old girl with chronic spontaneous urticaria 93
Interstitial Lung Disease in Children: “Specific Conditions of Undefined Etiology” Becoming Clearer 89
An overview on viral interference during SARS-CoV-2 pandemic 87
Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series 86
Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old Disease 86
Pathogenesis, diagnosis, dietary management, and prevention of gastrointestinal disorders in the paediatric population 85
UPDATE - 2022 Italian guidelines on the management of bronchiolitis in infants 85
Looking beyond pulmonary disease in COVID-19: A lesson from patients with cystic fibrosis 84
Food Allergies: Current and Future Treatments 83
Editorial: An overview on allergic and pulmonary diseases: from birth to childhood 82
An Italian Multicenter Study on the Epidemiology of Respiratory Syncytial Virus During SARS-CoV-2 Pandemic in Hospitalized Children 81
Foreign Body Aspiration in Children: Retrospective Case Series and Literature Update 81
Nasal microbiome in chronic rhinosinusitis 80
Efficacy and perceived satisfaction of 3-year SLIT in children with allergic rhinitis and asthma: a pilot study 80
Biologic drugs in chronic spontaneous urticaria 80
Impact of COVID-19 on the management of patients with Lysosomal Storage Disorders 76
Cutting-Edge Advances in Cystic Fibrosis: From Gene Therapy to Personalized Medicine and Holistic Management 75
Nonresponse to intramuscular vaccination: An unmet need in hepatitis B vaccination 73
The role of skin infections in atopic dermatitis in children 72
Effects of Vertical Transmission of Respiratory Viruses to the Offspring 68
Biochemical and genetic tools to predict the progression to Cystic Fibrosis in CRMS/CFSPID subjects: A systematic review 66
Type 2 inflammation in cystic fibrosis: New insights 66
HMGB1 as a Biomarker of Inhaled Corticosteroid Treatment Response in Moderate-Severe Asthmatic Children: A Single Center Pilot Study 62
Editorial: Nutrition, diet and allergic diseases 61
Long-term effects of bronchopulmonary dysplasia on lung function: a pilot study in preschool children’s cohort 59
Management of asthma exacerbations in the paediatric population: A systematic review 59
Paediatric Respiratory Diseases: From Clinical Experience to Literature Review 55
Pidotimod in allergic diseases 51
Correlation between RINT values and echocardiographic indices in pre-school children with chronic cough and wheezing 50
Efficacy and Safety of Pidotimod in Childhood Wheezing: A Pilot Study 49
Oral immunotherapy in children with allergic diseases: past, present and future 49
Observational study of sleep-related breathing disorders and preventive non-invasive ventilation in cystic fibrosis 48
COVID-19 ocular manifestation in children 48
Sleep Respiratory Disorders in Children and Adolescents with Cystic Fibrosis and Primary Ciliary Dyskinesia 47
Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab 44
An overview of HMGB1 and its potential role as a biomarker for RSV infection 43
Effectiveness of omalizumab in two children with severe vernal keratoconjunctivitis 40
Severe Asthma and Active SARS-CoV-2 Infection: Insights into Biologics 28
Lung Clearance Index: A New Measure of Ventilation Inhomogeneity in Childhood Respiratory Diseases 18
ARIA-Italy multidisciplinary consensus on nasal polyposis and biological treatments: Update 2025 2
Effect of Nirsevimab as a Primary Preventive Strategy on the Incidence, Severity, and Viral Etiology of Bronchiolitis: A Four‐Year Observational Study 1
Totale 5.536
Categoria #
all - tutte 16.288
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.288


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/202252 0 6 0 0 2 0 2 0 14 2 2 24
2022/2023245 14 4 13 19 16 44 10 35 60 2 8 20
2023/2024179 5 26 12 11 5 44 1 9 3 6 35 22
2024/2025968 16 88 27 37 110 224 54 28 59 87 114 124
2025/20264.073 220 478 448 301 584 844 334 111 232 218 229 74
Totale 5.536